There is limited information regarding the molecular epidemiology and antifungal susceptibilities of Candida isolates using the Neo-Sensitabs method in patients with vulvovaginal candidiasis (VVC). From August 2012 to March 2013, 301 non-pregnant patients aged 18-50 years with suspected VVC were prospectively screened at a teaching hospital in southern China. The vaginal isolates were identified by DNA sequencing of internal transcribed spacer and the D1/D2 domain. Antifungal susceptibility testing of seven antifungal agents was performed using the NeoSensitabs tablet diffusion method. Candida species were isolated from 186 cases (61.79 %). The most common pathogen was Candida albicans (91.4 %), followed by Candida glabrata (4.3 %), Candida tropicalis (3.2 %) and Candida parapsilosis (1.1 %). The susceptibility rates to C. albicans were higher for caspofungin, voriconazole and fluconazole than those for itraconazole, miconazole, ketoconazole and terbinafine (P,0.01). The resistance rates to C. albicans were 4.7, 6.5, 7.1, 7.6, 12.3, 27.7 and 74.7 % for caspofungin, miconazole, itraconazole, voriconazole, fluconazole, ketoconazole and terbinafine, respectively. No drugs tested apart from fluconazole exhibited differences in resistance between C. albicans and non-albicans Candida isolates. The results demonstrate that, using DNA sequencing, C. albicans is the most common isolate from Chinese patients with VVC. Caspofungin, voriconazole and fluconazole may be preferable to other azoles and terbinafine in the treatment of VVC.
INTRODUCTION
Approximately 75 % of healthy women experience at least one symptomatic episode of vulvovaginal candidiasis (VVC) during their lifetime (Mendling & Brasch, 2012) . Generally, 70-90 % of VVC cases are caused by Candida albicans, with others infected by non-albicans Candida (NAC) species including Candida glabrata sensu lato, Candida parapsilosis sensu lato, Candida tropicalis and Candida krusei (Ilkit & Guzel, 2011) . The prevalence of VVC due to NAC species is increasing, whereas NAC species are often more resistant to antifugal agents (Ilkit & Guzel, 2011; Mendling & Brasch, 2012) . Species identification of Candida isolates is obligatory in order to obtain epidemiological data and avoid antifungal failure. Although PCR-based assays are sensitive and specific for discrimination of Candida species (Mahmoudi Rad et al., 2012; Trama et al., 2005) , species differentiation is often performed on commercial biochemical panels. To date, the molecular epidemiology of VVC has rarely been reported (Gamarra et al., 2014; Mahmoudi Rad et al., 2012; Trama et al., 2005) .
Currently, agar-based susceptibility methods including disk diffusion and the E-test are feasible due to their simplicity, reproducibility and non-requirement for specialized equipment (Negri et al., 2009) . The Neo-Sensitabs tablet diffusion method offers simple, quick and costeffective susceptibility testing for determining the inhibition zone diameter of antifungal agents and is comparable to the Clinical and Laboratory Standards Institution (CLSI) M27-A2 assay for testing for yeasts and filamentous fungi in clinical laboratories (Espinel-Ingroff & Canton, 2008) . However, there is limited information regarding the NeoSensitabs method for antifungal susceptibility testing of Candida isolates in patients with VVC (Liu et al., 2014) .
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This study was undertaken to identify Candida species by DNA sequencing and to evaluate the antifungal susceptibility profile using the Neo-Sensitabs method in patients with VVC.
METHODS
Data collection. From August 2012 to March 2013, 301 non-pregnant patients aged 18-50 years with suspected VVC were prospectively screened at the Department of Obstetrics and Gynecology in our hospital. This study was approved by the ethics committee of our hospital (PJ2011013). VVC was clinically diagnosed on typical symptoms and positive results of direct microscopic examination and/or fungal culture, while recurrent VVC was defined as ¢ 4 episodes of VVC within a 12-month period. Exclusion criteria included systemic and topical use of antifungal and antibacterial agents in the previous month.
Vaginal samples were obtained from the posterior fornix with sterile swabs. The swabs were smeared onto glass slides in preparation for Gram-staining, cultured on Sabouraud dextrose agar medium with chloramphenicol and incubated at 27 uC for 14 days. Candida species were initially identified using KOH and slide culture techniques following growth of yeast colonies.
DNA sequence analysis. Genomic DNA was extracted by fungal DNA Mini kit (Omega). The internal transcribed spacer (ITS) including the 5.8S rRNA and 26S rRNA gene D1/D2 domains were amplified with primer pairs ITS1 (59-GTC GTA ACA AGG TTT CCG TAG GTG-39) and ITS4 (59-TCC TCC GCT TAT TGA TAT GC-39), and NL1 (59-GCA TAT CGG TAA GCG GAG GAA AAG-39) and NL4 (59-GGT CCG TGT TTC AAG ACG G-39), respectively (Yang et al., 2013) . The sequences of the ITS and D1/D2 domains were analysed using BLAST.
Antifungal susceptibility testing. The antifungal susceptibility testing of all Candida isolates was performed using Neo-Sensitabs (Rosco Diagnostica) according to the manufacturer's instructions.
Statistical methods. Statistical analysis was performed using SPSS, version 13.0. Susceptibility data were analysed by chi-squared test; P,0.05 was considered significant.
RESULTS
Of the 301 women with suspected VVC, Gram-stained smears of vaginal secretion showed Gram-positive blastsopores and pseudohyphae in 150 cases (49.83 %), while Candida species were isolated from 186 cases (61.79 %). There were 164 (88.2 %) non-recurrent and 22 (11.8 %) recurrent VVC cases. The ITS and D1/D2 domains were amplified and sequenced in 166 and 20 isolates, respectively, of which the D1/D2 domain was additionally performed in five strains with ambiguous ITS sequences. Based on DNA sequence analysis, C. albicans was the most common (170 strains, 91.4 %), followed by C. glabrata sensu stricto (eight, 4.3 %), C. tropicalis (six, 3.2 %) and C. parapsilosis sensu stricto (two, 1.1 %). Of these, 149 C. albicans, seven C. glabrata sensu stricto, six C. tropicalis and two C. parapsilosis sensu stricto strains were isolated from 164 non-recurrent cases, while 21 C. albicans and one C. glabrata sensu stricto strains were recovered from 22 recurrent cases. The ITS and D1/D2 sequences of 186 Candida species were deposited in GenBank and their accession numbers are shown in Table S1 (available in the online Supplementary Material).
C. albicans isolates were more susceptible to caspofungin, voriconazole and fluconazole than to itraconazole, miconazole, ketoconazole and terbinafine (P,0.01). Of the most susceptible agents, yeasts were more sensitive to caspofungin than to fluconazole (P50.036) but showed insignificant differences between caspofungin and voriconazole (P50.093). Although fluconazole-resistant NAC species were more common than C. albicans (P50.043), other drugs tested showed no differences in resistance between C. albicans and NAC species (Table 1) .
DISCUSSION
Based on traditional biochemical/morphological methods, overall percentages of VVC caused by C. albicans range from 46.9 to 85 % in various countries (Kalkanci et al., 2013; Konaté et al., 2014; Liu et al., 2014; Vijaya et al., 2014) . On the other hand, real-time PCR and pyrosequencing revealed that C. albicans (49.6 %) was the predominant pathogen in VVC cases, followed by C. glabrata (23.7 %), C. parapsilosis (13.3 %), C. tropicalis (9.6 %) and mixed infections (3.7 %) in the USA (Trama et al., 2005) . Multiplex PCR demonstrated that VVC cases were caused by C. albicans (65.1 %), NAC species (24.6 %) and mixed infections (10.3 %) in Iran (Mahmoudi Rad et al., 2012) . Species-specific PCR show that C. albicans was responsible for 85.2 % of VVC cases in Argentina (Gamarra et al., 2014) .
In this study, the prevalence of C. albicans (91.4 %) was similar to that of 85.2 % in Argentina (Gamarra et al., 2014) and 85 % in China (Liu et al., 2014) , but significantly higher than in other studies. C. glabrata sensu stricto was shown to be the second most common species, as in most studies, albeit at a lower percentage. Although only three NAC species-C. glabrata sensu stricto, C. tropicalis and C. parapsilosis sensu stricto-were recovered in our cases, 4-11 NAC species have frequently been isolated from VVC patients (Gamarra et al., 2014; Kalkanci et al., 2013; Konaté et al., 2014; Liu et al., 2014; Mahmoudi Rad et al., 2012; Vijaya et al., 2014) . Furthermore, in line with other authors (Gamarra et al., 2014; Kalkanci et al., 2013; Konaté et al., 2014; Vijaya et al., 2014) , mixed candidal infections were absent in our study. Therefore, our results demonstrate that C. albicans is still the principal pathogen in Chinese women with VVC. The variable distribution of Candida species may be mainly due to the disparity of geography, race, case selection and laboratory methods. Considering the identification of different Candida species is sometimes difficult based on conventional methods; PCR-based techniques are useful to differentiate these.
Antifungal susceptibility testing of Candida spp. isolated from VVC shows variation in results depending on the method utilized. Recently, E-test and CLSI reference methods have found that the resistance rates to C. albicans are 8.6 % for voriconazole, 1-19.1 % for itraconazole, 0-9.7 % for fluconazole, 0-2.6 % for ketoconazole and 12.7 % for miconazole (Gamarra et al., 2014; Kalkanci et al., 2013; Konaté et al., 2014; Liu et al., 2009; Vijaya et al., 2014) . The Neo-Sensitabs method showed that the resistance rates to C. albicans were 1.1, 2.2 and 4.2 % for fluconazole, itraconazole and miconazole, respectively (Liu et al., 2014) . The tablet diffusion method show that the resistance rates to 40 C. albicans isolates were 0 % for itraconazole, fluconazole and ketoconazole, but 25 % for miconazole (Gross et al., 2007) . In this study, however, the Neo-Sensitabs method demonstrated that the resistance rates to C. albicans were 4.7 % for caspofungin, 6.5 % for miconazole, 7.1 % for itraconazole, 7.6 % for voriconazole, 12.3 % for fluconazole, 27.7 % for ketoconazole and 74.7 % for terbinafine. Overall, C. albicans isolates were most sensitive to caspofungin, voriconazole and fluconazole, moderately sensitive to itraconazole, miconazole and ketoconazole, but resistant to terbinafine. Otherwise, most NAC strains were resistant to azoles (Liu et al., 2014) . Although all drugs tested apart from fluconazole exhibited no differences in resistance between C. albicans and NAC isolates in our study, the number of NAC strains may be insufficient to draw conclusions.
Caspofungin is one among echinocandin agents recommended as first-line therapy for candidaemia and invasive candidiasis, but 11.1 % of fluconazole-resistant bloodstream isolates of C. glabrata can be resistant to one or more echinocandins (Pfaller et al., 2012) . Although echinocandins are not applicable for VVC because of their cost and absence of oral and vaginal preparations, their usage for superficial candidiasis might be feasible in the future. Our results showed that the resistance rate of caspofungin was 4.7 % in vaginal C. albicans strains, although it was the most active of the seven drugs tested.
Among the azoles, the antifungal activity of voriconazole and fluconazole was superior to itraconazole, miconazole and ketoconazole in this study. Voriconazole may be preferable to fluconazole because of its broad-spectrum activity against Candida species (Vijaya et al., 2014) , but our results revealed no disparity between them. Moreover, all 40 C. albicans isolates were found susceptible to ketoconazole in Costa Rica (Gross et al., 2007) while 27.7 % of C. albicans species were resistant to ketoconazole in our study. Thus, whether ketoconazole resistance may be more common in Chinese women requires further investigation.
Terbinafine is among allylamine antifungals having fungistatic activity against C. albicans. Oral or topical terbinafine achieved good results in two small sample clinical observations (Ferahbas et al., 2006; Mahmoudabadi et al., 2013) . Nevertheless, although it was found less active against vaginal isolates of C. albicans (Gamarra et al., 2014) , 74.7 % of C. albicans strains were resistant to terbinafine in the present study. Terbinafine was less effective than itraconazole or fluconazole in murine VVC (Chen et al., 2007) . Therefore, large sample studies are required to determine the feasibility of terbinafine in the treatment of VVC.
Some limitations are present in our study. The antifungal testing results of Candida isolates from non-recurrent and recurrent patients were not analysed owing to insufficient recurrent cases. The statistical results of NAC antifungal testing may not reflect the real facts because of low numbers of strains. Moreover, the generalizability of our results is limited because screened patients originated from only one hospital.
In conclusion, our results demonstrate C. albicans to be the most common isolate from Chinese patients with VVC, using DNA sequencing. Caspofungin, voriconazole and fluconazole may be preferable to other azoles and terbinafine in the treatment of VVC.
